| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Diseases, Interstitial | 38 | 2026 | 675 | 7.260 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 9 | 2023 | 45 | 2.140 |
Why?
|
| Neuroendocrine Cells | 9 | 2020 | 34 | 2.000 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 7 | 2026 | 696 | 1.680 |
Why?
|
| Respiration Disorders | 5 | 2019 | 78 | 1.560 |
Why?
|
| Bronchoalveolar Lavage Fluid | 7 | 2019 | 641 | 1.470 |
Why?
|
| Hyperplasia | 12 | 2022 | 177 | 1.450 |
Why?
|
| Glycogen Storage Disease | 3 | 2021 | 19 | 1.350 |
Why?
|
| Lung | 30 | 2024 | 4141 | 1.120 |
Why?
|
| Child | 75 | 2026 | 22980 | 1.050 |
Why?
|
| Indoles | 3 | 2026 | 510 | 1.000 |
Why?
|
| Infant | 45 | 2026 | 10195 | 0.990 |
Why?
|
| Cystic Fibrosis | 7 | 2019 | 1171 | 0.880 |
Why?
|
| Child, Preschool | 40 | 2025 | 12017 | 0.820 |
Why?
|
| Proteomics | 6 | 2023 | 1205 | 0.810 |
Why?
|
| Pediatrics | 8 | 2015 | 1139 | 0.790 |
Why?
|
| Machine Learning | 2 | 2019 | 596 | 0.780 |
Why?
|
| Tomography, X-Ray Computed | 18 | 2026 | 2791 | 0.760 |
Why?
|
| Oxygen Inhalation Therapy | 5 | 2019 | 190 | 0.700 |
Why?
|
| Bronchiectasis | 3 | 2024 | 115 | 0.670 |
Why?
|
| Mutation | 14 | 2024 | 4130 | 0.660 |
Why?
|
| Humans | 112 | 2026 | 147306 | 0.640 |
Why?
|
| Biopsy | 16 | 2026 | 1093 | 0.630 |
Why?
|
| Immunologic Techniques | 1 | 2019 | 38 | 0.620 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2026 | 984 | 0.600 |
Why?
|
| Allergy and Immunology | 1 | 2019 | 43 | 0.590 |
Why?
|
| Asthma | 3 | 2019 | 1805 | 0.580 |
Why?
|
| Home Care Services | 2 | 2019 | 293 | 0.550 |
Why?
|
| Nocturnal Myoclonus Syndrome | 1 | 2018 | 6 | 0.550 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 2 | 2019 | 107 | 0.540 |
Why?
|
| Aptamers, Nucleotide | 1 | 2019 | 88 | 0.530 |
Why?
|
| Sleep Wake Disorders | 2 | 2020 | 315 | 0.530 |
Why?
|
| Inhalation Exposure | 2 | 2025 | 103 | 0.520 |
Why?
|
| Respiratory Function Tests | 12 | 2024 | 545 | 0.510 |
Why?
|
| Lung Diseases | 8 | 2020 | 787 | 0.500 |
Why?
|
| Hypoxia | 4 | 2018 | 1209 | 0.490 |
Why?
|
| Deoxycytosine Nucleotides | 2 | 2007 | 13 | 0.470 |
Why?
|
| Uridine | 2 | 2007 | 30 | 0.470 |
Why?
|
| Male | 54 | 2026 | 73954 | 0.460 |
Why?
|
| Adolescent | 35 | 2026 | 22826 | 0.450 |
Why?
|
| Female | 53 | 2026 | 80081 | 0.440 |
Why?
|
| Pulmonary Alveoli | 7 | 2021 | 389 | 0.440 |
Why?
|
| Pulmonary Surfactants | 8 | 2013 | 105 | 0.430 |
Why?
|
| Bronchiolitis Obliterans | 4 | 2024 | 61 | 0.420 |
Why?
|
| Hypertension, Pulmonary | 7 | 2024 | 1977 | 0.420 |
Why?
|
| Household Articles | 1 | 2014 | 28 | 0.400 |
Why?
|
| Clinical Clerkship | 6 | 2007 | 109 | 0.400 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 3 | 2010 | 7 | 0.390 |
Why?
|
| Disinfectants | 1 | 2014 | 45 | 0.390 |
Why?
|
| Research | 2 | 2020 | 435 | 0.390 |
Why?
|
| Growth Substances | 6 | 2000 | 138 | 0.370 |
Why?
|
| Respiration, Artificial | 4 | 2021 | 717 | 0.370 |
Why?
|
| Bronchiolitis | 1 | 2013 | 87 | 0.370 |
Why?
|
| Retrospective Studies | 25 | 2024 | 17561 | 0.350 |
Why?
|
| Polyendocrinopathies, Autoimmune | 1 | 2011 | 18 | 0.340 |
Why?
|
| ATP-Binding Cassette Transporters | 5 | 2014 | 117 | 0.340 |
Why?
|
| Neurosecretory Systems | 3 | 2010 | 31 | 0.340 |
Why?
|
| International Classification of Diseases | 1 | 2012 | 151 | 0.340 |
Why?
|
| Esophagoscopy | 3 | 2019 | 223 | 0.340 |
Why?
|
| Program Development | 2 | 2018 | 369 | 0.340 |
Why?
|
| Humidity | 1 | 2011 | 50 | 0.320 |
Why?
|
| Potassium Channels | 1 | 2011 | 148 | 0.320 |
Why?
|
| Fibroblast Growth Factors | 5 | 2000 | 188 | 0.320 |
Why?
|
| Dust | 1 | 2011 | 92 | 0.320 |
Why?
|
| Infant, Newborn | 17 | 2019 | 6543 | 0.310 |
Why?
|
| Computer Simulation | 4 | 2018 | 1018 | 0.310 |
Why?
|
| Rare Diseases | 3 | 2020 | 116 | 0.300 |
Why?
|
| Pulmonary Alveolar Proteinosis | 2 | 2023 | 17 | 0.300 |
Why?
|
| Education, Medical, Undergraduate | 3 | 2007 | 208 | 0.300 |
Why?
|
| Diagnosis, Differential | 6 | 2019 | 1518 | 0.300 |
Why?
|
| Problem-Based Learning | 4 | 2006 | 98 | 0.290 |
Why?
|
| Purinergic P2 Receptor Agonists | 2 | 2007 | 6 | 0.290 |
Why?
|
| Eosinophilic Esophagitis | 3 | 2019 | 333 | 0.280 |
Why?
|
| Immunologic Factors | 2 | 2011 | 261 | 0.270 |
Why?
|
| Pulmonary Fibrosis | 2 | 2024 | 395 | 0.270 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2024 | 703 | 0.270 |
Why?
|
| Genetic Testing | 3 | 2026 | 493 | 0.270 |
Why?
|
| Tomography | 2 | 2018 | 45 | 0.270 |
Why?
|
| Autoimmune Diseases | 3 | 2024 | 471 | 0.260 |
Why?
|
| Lung Injury | 1 | 2011 | 262 | 0.250 |
Why?
|
| Case-Control Studies | 6 | 2019 | 3660 | 0.250 |
Why?
|
| Cytokines | 2 | 2019 | 2087 | 0.250 |
Why?
|
| Respiratory Tract Diseases | 2 | 2019 | 178 | 0.250 |
Why?
|
| Curriculum | 2 | 2007 | 1083 | 0.250 |
Why?
|
| Practice Guidelines as Topic | 4 | 2024 | 1598 | 0.240 |
Why?
|
| Gastrointestinal Diseases | 2 | 2018 | 222 | 0.230 |
Why?
|
| United States | 13 | 2026 | 16313 | 0.230 |
Why?
|
| Pneumonia | 2 | 2019 | 636 | 0.230 |
Why?
|
| Vital Capacity | 2 | 2024 | 293 | 0.220 |
Why?
|
| Bronchodilator Agents | 1 | 2006 | 187 | 0.220 |
Why?
|
| Diarrhea | 1 | 2026 | 193 | 0.220 |
Why?
|
| Double-Blind Method | 3 | 2023 | 2080 | 0.210 |
Why?
|
| Disease Progression | 3 | 2024 | 2892 | 0.210 |
Why?
|
| Receptors, CCR2 | 1 | 2023 | 39 | 0.200 |
Why?
|
| Fibrosis | 2 | 2024 | 568 | 0.200 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2003 | 67 | 0.200 |
Why?
|
| Deglutition | 1 | 2024 | 73 | 0.200 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 347 | 0.190 |
Why?
|
| Pleural Effusion | 1 | 2003 | 60 | 0.190 |
Why?
|
| Severity of Illness Index | 4 | 2020 | 2974 | 0.180 |
Why?
|
| Biomarkers | 5 | 2019 | 4354 | 0.180 |
Why?
|
| Thyroid Nuclear Factor 1 | 3 | 2019 | 16 | 0.180 |
Why?
|
| Bronchoscopy | 3 | 2018 | 228 | 0.180 |
Why?
|
| Self-Evaluation Programs | 2 | 1999 | 5 | 0.180 |
Why?
|
| Treatment Outcome | 7 | 2026 | 11947 | 0.170 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2024 | 237 | 0.170 |
Why?
|
| Arthritis, Juvenile | 2 | 2019 | 64 | 0.170 |
Why?
|
| Education, Medical | 1 | 2005 | 277 | 0.170 |
Why?
|
| Immunocompromised Host | 2 | 2015 | 202 | 0.170 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2022 | 102 | 0.160 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2021 | 37 | 0.160 |
Why?
|
| Protein C | 1 | 2021 | 54 | 0.160 |
Why?
|
| Pulmonary Medicine | 2 | 2019 | 78 | 0.160 |
Why?
|
| Lung Transplantation | 3 | 2026 | 338 | 0.160 |
Why?
|
| Thinking | 1 | 2001 | 68 | 0.160 |
Why?
|
| Heart Defects, Congenital | 3 | 2018 | 941 | 0.150 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2000 | 68 | 0.150 |
Why?
|
| Proteolipids | 2 | 2000 | 28 | 0.150 |
Why?
|
| Foundations | 2 | 2020 | 27 | 0.150 |
Why?
|
| Heart Diseases | 1 | 2023 | 341 | 0.150 |
Why?
|
| Athetosis | 1 | 2019 | 7 | 0.150 |
Why?
|
| Respiratory Rate | 1 | 2019 | 25 | 0.150 |
Why?
|
| Congenital Hypothyroidism | 1 | 2019 | 10 | 0.150 |
Why?
|
| Chorea | 1 | 2019 | 13 | 0.150 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2001 | 116 | 0.150 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2019 | 17 | 0.140 |
Why?
|
| Digestive System Diseases | 1 | 2019 | 28 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2019 | 2458 | 0.140 |
Why?
|
| User-Computer Interface | 3 | 2006 | 165 | 0.140 |
Why?
|
| Societies | 1 | 2019 | 41 | 0.140 |
Why?
|
| Societies, Medical | 3 | 2026 | 914 | 0.140 |
Why?
|
| Preceptorship | 1 | 1999 | 67 | 0.140 |
Why?
|
| Air | 1 | 2018 | 44 | 0.140 |
Why?
|
| Oximetry | 1 | 2019 | 125 | 0.140 |
Why?
|
| Colorado | 6 | 2019 | 4591 | 0.130 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2019 | 121 | 0.130 |
Why?
|
| Bronchi | 2 | 2015 | 263 | 0.130 |
Why?
|
| Esophageal Mucosa | 1 | 2018 | 22 | 0.130 |
Why?
|
| Models, Anatomic | 1 | 2018 | 87 | 0.130 |
Why?
|
| Registries | 2 | 2025 | 2434 | 0.130 |
Why?
|
| Fibroblast Growth Factor 1 | 2 | 1996 | 13 | 0.130 |
Why?
|
| Respiratory Sounds | 2 | 2010 | 103 | 0.130 |
Why?
|
| Radiography | 3 | 2013 | 862 | 0.130 |
Why?
|
| Pneumonia, Lipid | 1 | 2017 | 3 | 0.130 |
Why?
|
| Respiration | 1 | 2018 | 208 | 0.130 |
Why?
|
| Educational Measurement | 1 | 2001 | 332 | 0.130 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 122 | 0.130 |
Why?
|
| Arteriovenous Anastomosis | 1 | 2017 | 13 | 0.130 |
Why?
|
| Bronchial Arteries | 1 | 2017 | 12 | 0.130 |
Why?
|
| Lymphocytes | 1 | 2019 | 378 | 0.130 |
Why?
|
| Research Design | 2 | 2023 | 1158 | 0.130 |
Why?
|
| Autophagy | 2 | 2022 | 291 | 0.130 |
Why?
|
| Virtual Reality | 1 | 2019 | 82 | 0.130 |
Why?
|
| Adult | 14 | 2024 | 41406 | 0.120 |
Why?
|
| Polysomnography | 1 | 2018 | 240 | 0.120 |
Why?
|
| Gastroesophageal Reflux | 2 | 2015 | 237 | 0.120 |
Why?
|
| Prognosis | 6 | 2024 | 4384 | 0.120 |
Why?
|
| Disease Management | 3 | 2019 | 654 | 0.120 |
Why?
|
| Membrane Proteins | 2 | 2022 | 1171 | 0.120 |
Why?
|
| Internal Medicine | 1 | 1999 | 280 | 0.120 |
Why?
|
| Down Syndrome | 1 | 2023 | 526 | 0.120 |
Why?
|
| Gastrostomy | 1 | 2018 | 130 | 0.120 |
Why?
|
| Pulmonary Artery | 2 | 2024 | 1132 | 0.120 |
Why?
|
| Mutation, Missense | 2 | 2014 | 337 | 0.110 |
Why?
|
| Bleomycin | 1 | 1997 | 256 | 0.110 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2019 | 303 | 0.110 |
Why?
|
| Family Practice | 1 | 1999 | 410 | 0.110 |
Why?
|
| Pulmonary Surgical Procedures | 1 | 2015 | 7 | 0.110 |
Why?
|
| Esophageal Atresia | 1 | 2015 | 32 | 0.110 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2015 | 35 | 0.110 |
Why?
|
| Referral and Consultation | 2 | 2026 | 886 | 0.110 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2015 | 40 | 0.110 |
Why?
|
| Comorbidity | 1 | 2020 | 1672 | 0.110 |
Why?
|
| Pregnancy Trimester, First | 1 | 2015 | 139 | 0.110 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 487 | 0.110 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 587 | 0.110 |
Why?
|
| Thyroid Gland | 1 | 2015 | 93 | 0.110 |
Why?
|
| Heart Rate | 1 | 2019 | 860 | 0.110 |
Why?
|
| Young Adult | 8 | 2019 | 14437 | 0.110 |
Why?
|
| Patient Satisfaction | 2 | 2019 | 718 | 0.110 |
Why?
|
| Pluripotent Stem Cells | 1 | 2015 | 81 | 0.110 |
Why?
|
| Clinical Competence | 3 | 2018 | 1260 | 0.110 |
Why?
|
| Gestational Age | 1 | 2018 | 997 | 0.110 |
Why?
|
| Angiography | 1 | 2015 | 209 | 0.110 |
Why?
|
| Delayed Diagnosis | 1 | 2015 | 101 | 0.100 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2014 | 45 | 0.100 |
Why?
|
| Forced Expiratory Volume | 3 | 2024 | 451 | 0.100 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 1072 | 0.100 |
Why?
|
| Phenotype | 3 | 2018 | 3216 | 0.100 |
Why?
|
| Chest Tubes | 1 | 2014 | 34 | 0.100 |
Why?
|
| Patient Care Team | 2 | 2018 | 712 | 0.100 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2014 | 56 | 0.100 |
Why?
|
| Electric Impedance | 3 | 2018 | 108 | 0.100 |
Why?
|
| Blood Proteins | 1 | 2015 | 239 | 0.100 |
Why?
|
| Diagnostic Techniques, Respiratory System | 1 | 2013 | 5 | 0.100 |
Why?
|
| Airway Obstruction | 1 | 2015 | 153 | 0.100 |
Why?
|
| Abnormalities, Multiple | 1 | 2015 | 199 | 0.100 |
Why?
|
| Cell Differentiation | 3 | 2015 | 2054 | 0.100 |
Why?
|
| Regeneration | 1 | 2015 | 198 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2018 | 794 | 0.100 |
Why?
|
| Deglutition Disorders | 1 | 2015 | 159 | 0.100 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 742 | 0.100 |
Why?
|
| DNA Mutational Analysis | 2 | 2013 | 414 | 0.100 |
Why?
|
| Homozygote | 1 | 2013 | 199 | 0.100 |
Why?
|
| Glycoproteins | 2 | 2000 | 358 | 0.100 |
Why?
|
| Pedigree | 2 | 2013 | 522 | 0.090 |
Why?
|
| Autoimmunity | 1 | 2019 | 935 | 0.090 |
Why?
|
| Device Removal | 1 | 2014 | 149 | 0.090 |
Why?
|
| Schools, Medical | 2 | 2007 | 159 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 5478 | 0.090 |
Why?
|
| Software | 1 | 1998 | 683 | 0.090 |
Why?
|
| Ambulatory Care | 1 | 2018 | 625 | 0.090 |
Why?
|
| Autoantibodies | 3 | 2019 | 1513 | 0.090 |
Why?
|
| Plethysmography | 1 | 2012 | 104 | 0.090 |
Why?
|
| Mucin-5B | 1 | 2015 | 234 | 0.090 |
Why?
|
| Familial Primary Pulmonary Hypertension | 2 | 2024 | 196 | 0.090 |
Why?
|
| World Health Organization | 1 | 2012 | 105 | 0.090 |
Why?
|
| Fibroblast Growth Factor 7 | 5 | 2000 | 15 | 0.090 |
Why?
|
| Fibroblast Growth Factor 10 | 5 | 2000 | 23 | 0.090 |
Why?
|
| Spirometry | 1 | 2012 | 235 | 0.090 |
Why?
|
| Leukocytes | 1 | 2013 | 301 | 0.090 |
Why?
|
| Hydrocortisone | 1 | 1994 | 300 | 0.090 |
Why?
|
| Models, Statistical | 1 | 2015 | 677 | 0.080 |
Why?
|
| Cardiac Catheterization | 1 | 2015 | 572 | 0.080 |
Why?
|
| Premature Birth | 1 | 2015 | 390 | 0.080 |
Why?
|
| Genetic Counseling | 2 | 2015 | 82 | 0.080 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 95 | 0.080 |
Why?
|
| Bronchoalveolar Lavage | 3 | 2007 | 90 | 0.080 |
Why?
|
| Critical Care | 1 | 2017 | 705 | 0.080 |
Why?
|
| Bromhexine | 1 | 2010 | 1 | 0.080 |
Why?
|
| Laryngeal Diseases | 1 | 2011 | 31 | 0.080 |
Why?
|
| Granulomatosis with Polyangiitis | 1 | 2011 | 47 | 0.080 |
Why?
|
| Physicians | 1 | 2019 | 961 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 5 | 1997 | 2542 | 0.080 |
Why?
|
| Internship and Residency | 2 | 2018 | 1279 | 0.080 |
Why?
|
| Epithelial Cells | 4 | 2015 | 1141 | 0.080 |
Why?
|
| Rats | 8 | 2000 | 5613 | 0.080 |
Why?
|
| Syndrome | 1 | 2011 | 385 | 0.080 |
Why?
|
| Rituximab | 1 | 2011 | 211 | 0.080 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 2011 | 96 | 0.080 |
Why?
|
| Endoscopy, Digestive System | 2 | 2024 | 142 | 0.080 |
Why?
|
| Nuclear Proteins | 2 | 2013 | 745 | 0.080 |
Why?
|
| Diagnostic Imaging | 2 | 2015 | 342 | 0.070 |
Why?
|
| Uniparental Disomy | 1 | 2009 | 9 | 0.070 |
Why?
|
| Microscopy, Electron | 3 | 2013 | 417 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 676 | 0.070 |
Why?
|
| Esophagus | 2 | 2024 | 262 | 0.070 |
Why?
|
| Uteroglobin | 2 | 2000 | 31 | 0.070 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2009 | 20 | 0.070 |
Why?
|
| Mucin-1 | 1 | 2009 | 29 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 2 | 2013 | 1940 | 0.070 |
Why?
|
| Body Mass Index | 1 | 2017 | 2470 | 0.070 |
Why?
|
| Cell Division | 4 | 2000 | 758 | 0.070 |
Why?
|
| Neutrophils | 1 | 2013 | 1135 | 0.070 |
Why?
|
| DNA | 2 | 2013 | 1444 | 0.070 |
Why?
|
| Cytogenetic Analysis | 1 | 2007 | 34 | 0.060 |
Why?
|
| Medical History Taking | 2 | 2005 | 119 | 0.060 |
Why?
|
| Lung Volume Measurements | 1 | 2007 | 47 | 0.060 |
Why?
|
| Consensus | 2 | 2020 | 476 | 0.060 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2007 | 63 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2013 | 1747 | 0.060 |
Why?
|
| DNA, Bacterial | 1 | 2007 | 320 | 0.060 |
Why?
|
| Respiratory Tract Infections | 1 | 2011 | 399 | 0.060 |
Why?
|
| Logistic Models | 3 | 2015 | 2142 | 0.060 |
Why?
|
| Cough | 1 | 2007 | 124 | 0.060 |
Why?
|
| Computer-Assisted Instruction | 1 | 2006 | 70 | 0.060 |
Why?
|
| Delphi Technique | 2 | 2018 | 347 | 0.060 |
Why?
|
| Administration, Inhalation | 2 | 2005 | 572 | 0.060 |
Why?
|
| Receptors, Purinergic P2Y2 | 1 | 2005 | 4 | 0.060 |
Why?
|
| Animals | 12 | 2019 | 38417 | 0.050 |
Why?
|
| Respiratory Mucosa | 2 | 2014 | 324 | 0.050 |
Why?
|
| Intraoperative Period | 2 | 2015 | 69 | 0.050 |
Why?
|
| Age Distribution | 1 | 2005 | 406 | 0.050 |
Why?
|
| Prospective Studies | 4 | 2023 | 8166 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 6011 | 0.050 |
Why?
|
| Vaping | 1 | 2025 | 81 | 0.050 |
Why?
|
| Faculty, Medical | 1 | 2007 | 308 | 0.050 |
Why?
|
| Program Evaluation | 2 | 2019 | 952 | 0.050 |
Why?
|
| Teaching | 1 | 2006 | 243 | 0.050 |
Why?
|
| Age of Onset | 1 | 2005 | 568 | 0.050 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2003 | 11 | 0.050 |
Why?
|
| T-Box Domain Proteins | 1 | 2024 | 106 | 0.050 |
Why?
|
| Patient Simulation | 1 | 2003 | 43 | 0.050 |
Why?
|
| Methylprednisolone | 2 | 2013 | 59 | 0.050 |
Why?
|
| Macrophages, Alveolar | 2 | 2023 | 377 | 0.050 |
Why?
|
| Autophagy-Related Proteins | 1 | 2022 | 46 | 0.040 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2022 | 51 | 0.040 |
Why?
|
| Bacteria | 1 | 2007 | 769 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2023 | 6099 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2003 | 298 | 0.040 |
Why?
|
| Data Collection | 1 | 2005 | 652 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2024 | 428 | 0.040 |
Why?
|
| Vesicular Transport Proteins | 1 | 2022 | 85 | 0.040 |
Why?
|
| Neuroblastoma | 1 | 2003 | 177 | 0.040 |
Why?
|
| Genotype | 2 | 2018 | 1875 | 0.040 |
Why?
|
| Terminology as Topic | 2 | 2018 | 261 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2022 | 173 | 0.040 |
Why?
|
| Cross-Cultural Comparison | 1 | 2001 | 84 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 241 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 4605 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2015 | 1281 | 0.040 |
Why?
|
| Surface-Active Agents | 1 | 2021 | 98 | 0.040 |
Why?
|
| Models, Educational | 1 | 2001 | 90 | 0.040 |
Why?
|
| RNA, Messenger | 4 | 2000 | 2812 | 0.040 |
Why?
|
| Group Processes | 1 | 2001 | 63 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 1730 | 0.040 |
Why?
|
| Pulmonary Surfactant-Associated Proteins | 2 | 2000 | 9 | 0.040 |
Why?
|
| Pemphigus | 1 | 1999 | 8 | 0.040 |
Why?
|
| Paraneoplastic Syndromes | 1 | 1999 | 14 | 0.040 |
Why?
|
| Heart | 1 | 2023 | 628 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 590 | 0.040 |
Why?
|
| Neoplasms | 1 | 2015 | 2946 | 0.040 |
Why?
|
| Developing Countries | 1 | 2001 | 318 | 0.040 |
Why?
|
| Speech-Language Pathology | 1 | 2019 | 24 | 0.040 |
Why?
|
| Incidence | 2 | 2019 | 2954 | 0.040 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 2 | 2000 | 31 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2013 | 481 | 0.040 |
Why?
|
| Esophageal pH Monitoring | 1 | 2018 | 22 | 0.040 |
Why?
|
| Hospital Information Systems | 1 | 1998 | 14 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2022 | 676 | 0.030 |
Why?
|
| Computer Communication Networks | 1 | 1998 | 32 | 0.030 |
Why?
|
| Survival Rate | 2 | 2019 | 2110 | 0.030 |
Why?
|
| Formative Feedback | 1 | 2018 | 36 | 0.030 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2019 | 121 | 0.030 |
Why?
|
| Efficiency, Organizational | 1 | 2019 | 141 | 0.030 |
Why?
|
| Interdisciplinary Research | 1 | 2018 | 26 | 0.030 |
Why?
|
| Students, Medical | 1 | 2002 | 380 | 0.030 |
Why?
|
| Fundoplication | 1 | 1997 | 52 | 0.030 |
Why?
|
| Drug Antagonism | 1 | 1997 | 10 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 1996 | 231 | 0.030 |
Why?
|
| Gene Expression | 3 | 2000 | 1481 | 0.030 |
Why?
|
| Hydroxyproline | 1 | 1997 | 18 | 0.030 |
Why?
|
| Macrophage Activation Syndrome | 1 | 2017 | 22 | 0.030 |
Why?
|
| Review Literature as Topic | 1 | 2017 | 53 | 0.030 |
Why?
|
| Otolaryngology | 1 | 2019 | 108 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2018 | 254 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 1998 | 123 | 0.030 |
Why?
|
| Hydrochloric Acid | 1 | 1996 | 9 | 0.030 |
Why?
|
| Cholera Toxin | 1 | 1996 | 29 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 1996 | 28 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2019 | 269 | 0.030 |
Why?
|
| Trachea | 1 | 2018 | 258 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 1999 | 1302 | 0.030 |
Why?
|
| Gastroenterology | 1 | 2019 | 191 | 0.030 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 1996 | 71 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2018 | 290 | 0.030 |
Why?
|
| Culture Media | 1 | 1996 | 161 | 0.030 |
Why?
|
| Organ Size | 1 | 1997 | 465 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2018 | 269 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 1996 | 208 | 0.030 |
Why?
|
| Xenopus | 1 | 2015 | 87 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2015 | 98 | 0.030 |
Why?
|
| Embryonic Induction | 1 | 1995 | 31 | 0.030 |
Why?
|
| Respiratory Insufficiency | 1 | 1999 | 330 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 3029 | 0.030 |
Why?
|
| Health Services Research | 1 | 2018 | 392 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2015 | 196 | 0.030 |
Why?
|
| Laminin | 1 | 1995 | 73 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 571 | 0.030 |
Why?
|
| Vimentin | 1 | 1995 | 54 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 283 | 0.030 |
Why?
|
| Mouth | 1 | 2015 | 86 | 0.030 |
Why?
|
| Autophagy-Related Protein 8 Family | 1 | 2014 | 2 | 0.030 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2015 | 61 | 0.030 |
Why?
|
| Proteostasis Deficiencies | 1 | 2014 | 6 | 0.030 |
Why?
|
| Sequestosome-1 Protein | 1 | 2014 | 15 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2014 | 2625 | 0.030 |
Why?
|
| Hepatocyte Growth Factor | 1 | 1994 | 33 | 0.030 |
Why?
|
| Vacuoles | 1 | 2014 | 39 | 0.030 |
Why?
|
| Proteoglycans | 1 | 1995 | 112 | 0.030 |
Why?
|
| North America | 1 | 2015 | 307 | 0.030 |
Why?
|
| Long-Term Care | 1 | 2015 | 118 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2014 | 75 | 0.030 |
Why?
|
| Mice | 3 | 2019 | 18493 | 0.030 |
Why?
|
| Fatal Outcome | 2 | 2009 | 306 | 0.030 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2015 | 139 | 0.030 |
Why?
|
| Mesoderm | 1 | 1995 | 147 | 0.030 |
Why?
|
| Culture Techniques | 1 | 1994 | 66 | 0.030 |
Why?
|
| Cardiovascular Agents | 1 | 2015 | 166 | 0.030 |
Why?
|
| Lysosomes | 1 | 2014 | 133 | 0.030 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2014 | 76 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2019 | 697 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2015 | 214 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 1 | 1994 | 93 | 0.030 |
Why?
|
| Prevalence | 2 | 2011 | 2889 | 0.030 |
Why?
|
| Consanguinity | 1 | 2013 | 50 | 0.030 |
Why?
|
| Drug Combinations | 1 | 1995 | 399 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 135 | 0.020 |
Why?
|
| Rats, Inbred F344 | 3 | 2000 | 269 | 0.020 |
Why?
|
| ROC Curve | 1 | 2015 | 626 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 2013 | 79 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2014 | 303 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 878 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 1995 | 1049 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 197 | 0.020 |
Why?
|
| Hydroxychloroquine | 1 | 2013 | 65 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2014 | 173 | 0.020 |
Why?
|
| Drainage | 1 | 2014 | 189 | 0.020 |
Why?
|
| Azithromycin | 1 | 2013 | 101 | 0.020 |
Why?
|
| Siblings | 1 | 2013 | 197 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 199 | 0.020 |
Why?
|
| Laparoscopy | 1 | 1997 | 486 | 0.020 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1994 | 171 | 0.020 |
Why?
|
| Collagen | 1 | 1995 | 460 | 0.020 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2015 | 229 | 0.020 |
Why?
|
| Transcriptome | 1 | 2019 | 1059 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 189 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 745 | 0.020 |
Why?
|
| Pandemics | 1 | 2020 | 1720 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2019 | 3153 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2013 | 227 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 430 | 0.020 |
Why?
|
| Pregnancy | 2 | 2015 | 7276 | 0.020 |
Why?
|
| Dexamethasone | 1 | 1994 | 368 | 0.020 |
Why?
|
| Denmark | 1 | 2011 | 51 | 0.020 |
Why?
|
| Algorithms | 2 | 2015 | 1868 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 36821 | 0.020 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2015 | 394 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2015 | 892 | 0.020 |
Why?
|
| Risk Factors | 2 | 2015 | 11017 | 0.020 |
Why?
|
| Granuloma | 1 | 2011 | 97 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 2017 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 1995 | 4170 | 0.020 |
Why?
|
| Laryngostenosis | 1 | 2011 | 54 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 1253 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 2197 | 0.020 |
Why?
|
| Cell Line | 1 | 2015 | 2832 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2009 | 28 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2009 | 36 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 566 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2015 | 1912 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2000 | 58 | 0.020 |
Why?
|
| Genes, rRNA | 1 | 2007 | 38 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2013 | 722 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 6042 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 7173 | 0.020 |
Why?
|
| Mitochondria | 1 | 2014 | 1000 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 2007 | 152 | 0.020 |
Why?
|
| Endocrine System Diseases | 1 | 2007 | 35 | 0.020 |
Why?
|
| Growth Disorders | 1 | 2007 | 89 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2014 | 723 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 928 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2015 | 3784 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2011 | 1845 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 2007 | 288 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 2886 | 0.010 |
Why?
|
| CD-ROM | 1 | 2003 | 5 | 0.010 |
Why?
|
| Teaching Materials | 1 | 2003 | 22 | 0.010 |
Why?
|
| Proteins | 2 | 2000 | 1024 | 0.010 |
Why?
|
| Signal Transduction | 1 | 1996 | 5272 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2015 | 3022 | 0.010 |
Why?
|
| Inflammation | 1 | 2014 | 2921 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 430 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2003 | 307 | 0.010 |
Why?
|
| Korea | 1 | 2001 | 18 | 0.010 |
Why?
|
| Adenovirus Infections, Human | 1 | 2001 | 15 | 0.010 |
Why?
|
| Pneumonia, Mycoplasma | 1 | 2001 | 56 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2000 | 77 | 0.010 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2000 | 30 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2000 | 318 | 0.010 |
Why?
|
| Acantholysis | 1 | 1999 | 2 | 0.010 |
Why?
|
| Castleman Disease | 1 | 1999 | 16 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2003 | 1492 | 0.010 |
Why?
|
| Epithelium | 1 | 1999 | 311 | 0.010 |
Why?
|
| Internet | 1 | 2003 | 696 | 0.010 |
Why?
|
| Adolescent Behavior | 1 | 2003 | 498 | 0.010 |
Why?
|
| Lymphoma, B-Cell | 1 | 1999 | 151 | 0.010 |
Why?
|
| Phospholipases A | 1 | 1997 | 97 | 0.010 |
Why?
|
| Physical Examination | 1 | 1998 | 245 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1998 | 284 | 0.010 |
Why?
|
| Cell Count | 1 | 1996 | 321 | 0.010 |
Why?
|
| Influenza, Human | 1 | 2001 | 634 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1999 | 901 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 1994 | 76 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2002 | 1220 | 0.010 |
Why?
|
| Age Factors | 1 | 2000 | 3372 | 0.010 |
Why?
|